Press release
Segmentation, Major Trends, and Competitive Overview of the Locally Advanced Pancreatic Cancer Market
Locally Advanced Pancreatic Cancer Market
Steady Growth Forecast for the Locally Advanced Pancreatic Cancer Market Size Until 2030
The market size for locally advanced pancreatic cancer is projected to expand swiftly, reaching $1.71 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 10.2%. Several factors contribute to this upward trajectory, including the broadening use of combination therapy protocols and the increasing adoption of stereotactic body radiation therapy (SBRT). Additionally, enhanced funding for pancreatic cancer research, a growing focus on personalized oncology approaches, and the rising availability of specialized treatment centers are crucial drivers. Key trends during this period will include a greater reliance on combination chemotherapy regimens, more extensive utilization of neoadjuvant treatments, a heightened emphasis on tumor downstaging to improve surgical eligibility, the expansion of radiation therapy for local disease management, and a multidisciplinary approach to treatment planning.
Download a free report of the locally advanced pancreatic cancer market report:
https://www.thebusinessresearchcompany.com/report/locally-advanced-pancreatic-cancer-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Leading Players Shaping the Locally Advanced Pancreatic Cancer Market
The market is dominated by several pharmaceutical and biotechnology giants. Key players include Pfizer Inc, F Hoffmann La Roche Ltd, Merck and Co Inc, Bristol Myers Squibb Company, AstraZeneca plc, AbbVie Inc, Novartis AG, GSK plc, Bayer AG, Eli Lilly and Company, Ipsen, Takeda Pharmaceutical Company Limited, Amgen Inc, Sanofi, Servier, NovoCure Limited, Halozyme Therapeutics, Clovis Oncology, Astellas Pharma, and BeiGene.
Significant Acquisition to Strengthen Oncology Portfolio by AstraZeneca
In June 2024, AstraZeneca Plc, a UK-based pharmaceutical company, enhanced its position in the oncology sector by acquiring Fusion Pharmaceuticals Inc. for $2.5 billion. This strategic acquisition aims to bolster AstraZeneca's portfolio with advanced radiopharmaceutical therapies, including FPI-2265. It also seeks to improve research and manufacturing capacities while accelerating the company's transition towards targeted cancer treatments. Fusion Pharmaceuticals, based in Canada, focuses on developing targeted therapies for various cancers, including pancreatic cancer, making this acquisition a vital step in expanding AstraZeneca's footprint in the Canadian market and beyond.
View the full locally advanced pancreatic cancer market report:
https://www.thebusinessresearchcompany.com/report/locally-advanced-pancreatic-cancer-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Positive Trends Boosting Locally Advanced Pancreatic Cancer Market Growth
Innovative technological advancements are among the key trends supporting market growth. Particularly, the integration of AI-assisted detection systems is becoming prominent in related fields to improve early diagnosis and treatment decisions. These AI technologies analyze medical imaging in real time to identify abnormalities, providing visual alerts that aid clinicians without requiring additional interventions.
For example, in September 2024, Odin Medical Ltd., a US-based company linked with Olympus Corporation, introduced CADDIE, a cloud-based AI endoscopic system. CADDIE uses cloud computing to analyze colonoscopy videos live, pinpointing possible colorectal polyps and helping endoscopists make informed choices during procedures. Clinical trials showed that this technology enhances the adenoma detection rate without prolonging procedures or increasing risks, demonstrating its value in improving early cancer detection and patient outcomes.
Detailed Segmentation of the Locally Advanced Pancreatic Cancer Market
This market is categorized across several dimensions to provide a comprehensive overview:
1) Therapy Type:
- Chemotherapy
- Radiation Therapy
2) Route of Administration:
- Oral
- Injectables
- Other Routes of Administration
3) End-User:
- Hospitals
- Specialty Clinics
- Research Institutions
- Other End-Users
Further subsegments include:
- Chemotherapy Types: Gemcitabine-based Chemotherapy and FOLFIRINOX Chemotherapy
- Radiation Therapy Types: External Beam Radiation Therapy and Stereotactic Body Radiation Therapy (SBRT)
This segmentation highlights the diverse therapeutic approaches, administration methods, and healthcare settings involved in managing locally advanced pancreatic cancer.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Segmentation, Major Trends, and Competitive Overview of the Locally Advanced Pancreatic Cancer Market here
News-ID: 4481147 • Views: …
More Releases from The Business Research Company
Market Segmentation, Major Trends, and Competitive Analysis of the Biosimilar Mo …
The biosimilar monoclonal antibodies market is poised for substantial expansion in the upcoming years, driven by a combination of scientific advancements and increasing healthcare demands. This growing sector is expected to play a vital role in making biologic therapies more accessible and affordable worldwide, particularly as more biosimilars gain acceptance and regulatory support.
Projected Growth of the Biosimilar Monoclonal Antibodies Market
The global biosimilar monoclonal antibodies market is forecasted to…
Leading Companies Reinforcing Their Presence in the Biosimilar Growth Hormones M …
The biosimilar growth hormones industry is positioned for significant expansion over the coming years, driven by several key developments in the healthcare sector. With advances in biosimilar approvals and changing treatment preferences, this market is set to transform the way growth hormone therapies are delivered and accessed globally. Let's explore the current market size, main players, emerging trends, and segment outlook within this evolving industry.
Market Size Outlook and Growth Potential…
Market Driver Insights: The Impact of Recent Advancements on the Biopharmaceutic …
The biopharmaceutical fermentation systems market is set to experience significant expansion in the coming years, driven by various technological advances and rising demand in the biopharma sector. This market is evolving rapidly as companies seek efficient and scalable fermentation solutions to meet the growing need for biologics and personalized medicines. Below, we dive into the market's size, key players, emerging trends, and segmentation to understand its future trajectory.
Projected Growth and…
Market Driver Analysis: The Impact of Recent Advances on the Enzyme Inhibitor Ma …
The enzyme inhibitor market is on a steady upward trajectory, driven by advancements in medical science and expanding applications across various fields. As demand for precise and effective therapies grows, this market is set to witness significant development through 2030. Here is an in-depth look at the market size, key players, influential trends, and segmentation that define this evolving sector.
Forecasted Expansion of the Enzyme Inhibitor Market Size Through 2030 …
More Releases for Locally
Peyman Farzinpour on Why Arts Access Matters Locally
Image: https://www.globalnewslines.com/uploads/2026/02/1770823176.jpg
Peyman Farzinpour, Los Angeles, California
Peyman Farzinpour, Los Angeles-based conductor and educator, reflects on how access to the arts shapes individuals, communities, and the future of creative work in Southern California.
Los Angeles, CA - National conversations about arts access often focus on big-picture funding and policy debates. But for Peter Peyman Farzinpour, the issue is grounded in everyday experience. As a conductor, composer, educator, and arts leader with deep professional…
Justin Brewer Highlights How Hidden Business Costs Hit Connecticut Locally
Connecticut, US, 14th January 2026, ZEX PR WIRE, Entrepreneur and Greenhub Founder Justin Brewer, originally from Somers, Connecticut, is drawing attention to a broader issue he says quietly affects many local businesses: confusing systems and hidden operating costs that drain time, energy, and margins. In a recent feature interview, Brewer reflected on how this challenge shows up not only nationally, but right across Northern Connecticut and the wider New England…
Communicate Locally with Professional Business Translation Services to Compete G …
If you can't communicate locally, you won't be able to compete globally. It is the first rule of business communication, which helps you position yourself better to do business in communities all over the world. Professional business translation services help you reach out to your target audience in an international market and build meaningful connections without any language barrier.
Semantics is a reputed translation service provider in more than 150 languages…
Arch House Deli – launches range of locally inspired hampers
Arch House Deli (Clifton Village, Bristol, UK) has launched a range of hampers based on food from local producers in Bristol and Bath.
During 2012 the deli has built relationships with local niche food suppliers and has developed a range of hampers selecting the very best from the Bristol and Bath area.
“Our vision for our products is to source local, sustainable, traceable and organic where ever possible. Only if…
BluePrint Data Provides Free Locally Installable OEM Internet Filtering Software
OEM Internet Filtering provider and leader in high quality OEM internet content filtering solutions BluePrint Data is expanding its integration tools and utilities with the addition of a locally installable “Content Engine”. The configurable software, provided free by BluePrint Data, enables companies to have a locally installable “URL Lookup” tool for a plethora of devices from local home or small business routers to network gateway appliances or data center…
Locally Made Skincare Products Outperform Major Companies
Customers from around the world write in to share how Natural Family Botanical skincare products have succeeded where store-bought products have failed. G
Merlin, OR - November, 2010 -- Devised with a fresh perspective and all-natural ingredients, there are no better products for sensitive or reactive skin than the formulas of Kelly Frohnauer, founder and owner of Natural Family Botanicals.
Men and women of all ages are discovering their true reflections, free…
